Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Doubtful you are also an expert in biology. I believe as you just posted here, "a proof of delusion."
I think you're preaching to the choir but I like how you sing, Misiu!
The trend is your friend is not Mr. Hanley - he's an anachronism for some special folk.
some say tomato, others tomatoe
I would like to make something really clear. I agree completely with Blueheel1 regarding Cyrus’s purchase of CYDY stock.
Let me repeat it: Cyrus’s purchase was not an award. He bought shares on the open market for $100,000. Who the heck has that kind of money? Who would buy CYDY shares now? Better yet, why?
Blueheel1 wrote: “At some point, it will become clear to everyone on here: we are not Nader-land anymore.”
I agree too with his summary: “My understanding is that the FDA had one clarification question from our submission of the hold data,” which they needed to address. It was very minor and it was answered within one to two days. I maintain that the hold will be lifted shortly, (although this probably pushes the scenario out a week to maybe mid-March).
Cyrus will graduate from president to CEO and it is contingent upon the hold being lifted. A partnership for oncology/solid tumor trials will follow shortly after that. Further, the company will change their name this calendar year and totally rebrand - which is appropriate given that Cyrus has fired everyone responsible for its mismanagement.
They will also start a Nash trial this year. Nash is a huge market and there is room for 5-6 players (similar to type 2 diabetes) – AND we will be one of them.
We will win an award against Amarex this year. It will be north of FIFTY MILLION!
ALSO, and I shout his sentiment from the rooftops: Add shares at these levels if you have the $.
what's your point?
And, can't sell this POS either!
That is totally incorrect. You need to start showing that you are correct by citing all those trials that failed.
Are you sure about that? Fuel cells are not on hold just an emergent industry at the moment.
How many mj boards have you posted that same sentence?
Which company? Bioxy or Todos?
When is the wind not blowing?
The short borrow rate on our beloved stock today is 45.7%! Who wants to short?
I can vouch that the CEO of Todos needs help. Great product but the company continues to lose money..
You don't think they're dirt cheap now? Charlotte's Web is more than half of what it was eighteen months ago. $.48 cents! What? And you think, oh, it's going to drop more this summer, like what, fifteen cents more?
Who the f**** cares at this point. These prices hark for damaging the economy too.
Let's say it is: Ballard and PLUG have more to be concerned than FCEL.
Almost ALL mj companies are down precipitously.
That's funny.
Let's replace the word CytoDyn with the word LIFE.
We still have a partnership with Exxon. How big is this planet? How many companies will eventually buy into Carbon storage and the Hydrogen evolution? How many companies can FCEL support? Always room to grow. Don't need everyone.
That expired penicillin did help. We're up 2 cents to .30!
Written off inventory is not the same as expired drug.
Let’s say you had strep throat and the doc says to you, “I can give you a shot of penicillin (it was manufactured five years ago) or I can give you a glass of lemonade.
What would you choose?
I don’t know you at all but I love all of your posts. You make my day!
That's a grandstand, yes!
Agree.
I've been driving a car for 50+ years but I have no idea how the engine really works. I guess I am as clueless as Biden, yet I find myself here, investing in a carbon neutral technology - just like Biden.
Biden is in favor. Are you?
Okay, so let's delve into HH's statement here. Specifically, I think, HH left out a word or two - in our favor. "Bull market has almost officially begun." I say yes with a huge caveat. HH should have written: " FCEL Bull Market had almost officially begun." Now why? Today's headline over energy - Big Energy: How soon will it be until the world reaches 'peak oil'?
A report by oil giant BP predicts that the world will sharply reduce its reliance on the company's signature product, oil and gas, over the next 25 years.
25+2023 = 2048: "In its annual energy outlook, BP said that fossil fuels, which it said accounted for 80% of energy usage in 2019, would fall to just 20% by 2050."
What does that say about FCEL's Carbon capture? I say, "Big Slice of Apple Pie!" with a glass of water vapor on the side.
“The continuing rise in carbon emissions and the increasing frequency of extreme weather events in recent years highlight more clearly than ever the importance of a decisive shift towards a net-zero future,” Spencer Dale, the chief economist at BP, wrote in a forward to the report. (Dale's report filled with all sorts of tips and bits: https://www.bp.com/en/global/corporate/energy-economics/energy-outlook/foreword.html
The article: https://www.yahoo.com/news/how-soon-will-it-be-until-the-world-reaches-peak-oil-234257102.html
Maybe it’s you tube…
Wrong message
For those that can't read - from page 18:
"ExxonMobil is working with FuelCell Energy to substantially improve the efficiency, effectiveness and affordability of carbon capture through fundamental research into a novel technology that uses proprietary carbonate fuel cells to concentrate carbon dioxide from large-scale industrial and power plants."
What part is clear?
Old news. That was 2022, 2021, 2020.
This is 2023. Quote 2023. I did, early this morning.
Of course that is your take, your description; however, let's look at another company right now that is half of CYDY with a mab that does not have the Stats of Leronlimab.
I say fight like hell if you are CYDY or Humanigen.
Here's another paragraph from the PubMed article that carries a powerful message:
"Subcutaneous PRO 140 demonstrated potent and prolonged antiretroviral activity. Mean log(10) reductions in HIV-1 RNA level were 0.23, 0.99 (P=.009), 1.37 (P<.001), and 1.65 (P<.001) for the placebo, 162 mg weekly, 324 mg biweekly, and 324 mg weekly dose groups, respectively. Viral loads remained suppressed between successive doses. Treatment was generally well tolerated."
While we are on the subject of Pro 140 aka Leronlimab, does anyone remember these published stats?? This is about Leronlimab, the mab that does it in spades - it's the one where one of our posters had repeatedly stated that it has no side effects. NONE!
And I quote: "Subcutaneous PRO 140 demonstrated potent and prolonged antiretroviral activity. Mean log(10) reductions in HIV-1 RNA level were 0.23, 0.99 (P=.009), 1.37 (P<.001), and 1.65 (P<.001) for the placebo, 162 mg weekly, 324 mg biweekly, and 324 mg weekly dose groups, respectively. Viral loads remained suppressed between successive doses. Treatment was generally well tolerated."
Happy New Year - still in 2022. All will be reading more about the stunning results of your favorite subject here.
What, exactly, do you not agree with?
Good!
Happy to not take your advice and NOT selling.
I am specifically addressing Pro 140. You keep on harping on Nader who has been a serious distraction to Pro 140. Maybe 2023 has some benefit.